1-5 of 5
Giuseppe Gritti
Close
Sort by
Journal Articles

Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma

Clinical Trials & Observations
Giuseppe Gritti, Anton Belousov, James Relf, Mark Dixon, Maneesh Tandon, Krishna Komanduri
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3615–3618.
https://doi.org/10.1182/bloodadvances.2023011089
Published: 2024
Includes: Supplemental data
Journal Articles

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

Clinical Trials & Observations
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta-Shah, Julie Lisano, Rachael Wen, Alev Akyol, Alison J. Moskowitz
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5272–5280.
https://doi.org/10.1182/bloodadvances.2023010254
Published: 2023
Includes: Supplemental data
Journal Articles

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Clinical Trials & Observations
Emmanuel Bachy, Kerry J. Savage, Huiqiang Huang, Yok-Lam Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Haiyan Yang, Siguo Hao, Jianda Hu, Keshu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José María Ferreri, Gandhi Laurent Damaj, Hui Liu, Wei Zhang, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4435–4447.
https://doi.org/10.1182/bloodadvances.2022009575
Published: 2023
Includes: Supplemental data
Journal Articles

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

Clinical Trials & Observations
Luca Ceriani, Giuseppe Gritti, Luciano Cascione, Maria Cristina Pirosa, Angela Polino, Teresa Ruberto, Anastasios Stathis, Andrea Bruno, Alden A. Moccia, Luca Giovanella, Stefanie Hayoz, Sämi Schär, Stefan Dirnhofer, Alessandro Rambaldi, Giovanni Martinelli, Christoph Mamot, Emanuele Zucca
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1082–1092.
https://doi.org/10.1182/bloodadvances.2019001201
Published: 2020
Journal Articles

Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models

Chiara Tarantelli, Martin Lange, Eugenio Gaudio, Luciano Cascione, Filippo Spriano, Ivo Kwee, Alberto J. Arribas, Andrea Rinaldi, Thibaud Jourdan, Melanie Berthold, Andrea Sturz, Carolyn Sperl, Francesco Margheriti, Lorenzo Scalise, Giuseppe Gritti, Davide Rossi, Anastasios Stathis, Ningshu Liu, Emanuele Zucca, Oliver Politz, Francesco Bertoni
Journal: Blood Advances
Blood Adv (2020) 4 (5): 819–829.
https://doi.org/10.1182/bloodadvances.2019000844
Published: 2020
Includes: Supplemental data